| NCT Number | NCT07109323 |
| Lead Sponsor | Institute of Hematology & Blood Diseases Hospital, China
Collaborators: Hebei Taihe Chunyu Biotechnology Co., Ltd |
| Conditions | Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm Definitions, Cytogenetics Ultra High Risk, Primary Refractory, Early Progression, Plasma Cell Leukemia, Non Paraosseous Extramedullary Infiltration, R2-ISS-IV /MPSS-IV |
| Enrollment | 50 participants |
| Start Date | 2025-03-03 |
| Primary Completion | 2028-03-02 (estimated) |
| Study Completion | 2030-03-02 (estimated) |
| Updated on ClinicalTrials.gov | 2025-08-07 |